Tani reports, “The focus of the story is a company called Safety Shot, which makes a drink it claims lowers blood alcohol content and can quickly sober up people who have been drinking. Hunterbrook’s report, edited by founder Sam Koppelman, said the product didn’t work.
“But Hunterbrook’s story did not disclose that Koppelman is an investor in another company in the same space, ZBiotics. Koppelman acknowledged, after Semafor reviewed documents showing the investment, that he has a small personal stake in the supplement startup, which on its website promises to help drinkers prevent hangovers.
“The pitch is not unlike that made by Safety Shot. While Hunterbrook’s article focuses on Safety Shot’s claim that it sobers you up after drinking, Safety Shot also markets itself as a hangover cure or preventer, the crux of ZBiotics’ product.”
Read more here.
Reuters has hired Wen-Yee Lee to be its tech correspondent in Taiwan. She has been…
NPR tech reporter Dara Kerr has left the news organization for a new opportunity. Kerr…
Fox Business host Larry Kudlow has no plans to leave his role amid reports detailing…
Morgan Meaker, a senior writer for Wired covering Europe, is leaving the publication after three…
Nick Dunn, who is currently head of CNBC Events as senior vice president and managing…
Wall Street Journal editor in chief Emma Tucker sent out the following on Friday: Dear…